Katsuhiko Higuchi

Sagamihara, 2520374, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: August 10, 2018

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

Journal: Surgery today

Published: July 22, 2016

Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).

Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).

Journal: Anti-cancer drugs

Published: June 03, 2016

Actinomyces denticolens colonisation identified in equine tonsillar crypts.

Actinomyces denticolens colonisation identified in equine tonsillar crypts.

Journal: Veterinary record open

Published: November 11, 2015

Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy.

Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy.

Journal: Japanese journal of radiology

Published: September 02, 2015

Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment.

Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment.

Journal: Anticancer research

Published: February 11, 2015

Diagnostic value of blood gene expression signatures in active tuberculosis in Thais: a pilot study.

Diagnostic value of blood gene expression signatures in active tuberculosis in Thais: a pilot study.

Journal: Genes and immunity

Published: November 07, 2014

Protective effect of hypotaurine against oxidative stress-induced cytotoxicity in rat placental trophoblasts.

Protective effect of hypotaurine against oxidative stress-induced cytotoxicity in rat placental trophoblasts.

Journal: Placenta

Published: October 11, 2014

Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).

Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).

Journal: International journal of radiation oncology, biology, physics

Published: December 07, 2013

Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801/BIRIP trial).

Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801/BIRIP trial).

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 28, 2013

Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.

Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 07, 2013

DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.

DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.

Journal: World journal of gastroenterology

Published: June 07, 2013

Showing 1-12 of 34

Last Updated: 09/26/2026